Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4561-4570 Newer>

The Motley Fool February 4, 2008 Chuck Saletta	Best International Stock: Teva Pharmaceutical A quick summary of Israel's Teva Pharmaceutical, the world's largest generic drugmaker.
Managed Care January 2008 Frank Diamond	Leading With Its Heart Program Geisinger Health System's "warranty" for CABG surgery has gotten a lot of attention, but is it transplantable?
Managed Care January 2008 Thomas Kaye	Now Is the Time for Pharmacy Performance Incentives We've made strides in increasing the transparency of pricing in the pharmacy supply chain, and now we need to change dispensing behavior.
Managed Care January 2008 John Carroll	Plans Look Askance at Me-Too Medications Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug.
Managed Care January 2008 John A. Marcille	Higher Quality Does Mean Lower Cost at Geisinger Geisinger Health System's ProvenCare program seems to work for both sides, and if it does, there is no reason, in principle, that it cannot work with hospitals and plans that are unrelated.
Managed Care January 2008 Michael L. Millenson	Geisinger CABG Warranty: A Worthwhile Experiment As an idea, Geisinger's ProvenCare program is a winner. What happens in the marketplace remains to be seen.
Managed Care January 2008 Martin Sipkoff	Should Pharmacists Be Allowed To Vaccinate Their Patients? Although federal health agencies support the idea of having pharmacists administer vaccines to their patients, the roadblock continues to be a question of payment.
The Motley Fool February 1, 2008 Brian Lawler	Alexion Looks for a Bigger Niche Alexion Pharmaceutical announces sales of its rare blood disorder medication should expand in 2008.
The Motley Fool February 1, 2008 Brian Lawler	Credit Crisis Bites Big Pharma Bristol-Myers Squibb takes a $275 million writedown in its investment portfolio for the quarter.
The Motley Fool February 1, 2008 Anders Bylund	Intuitive Surgical Just Makes Sense The company blew past analyst estimates and management guidance. The stock price has tripled in just one year, with a breathtaking 2,500% five-year return.
<Older 4561-4570 Newer> Return to current articles.